Butabarbital decreases results of sufentanil SL by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Keep an eye on Intently. Coadministration of CYP3A4 inducers might lessen sufentanil levels and efficacy, quite possibly precipitating withdrawal syndrome in sufferers that have designed physical dependence to sufentanil. Discontinuation of concomitantly utilized ... https://charlesq134mno8.loginblogin.com/profile